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Background. The risk of suicidal tendencies in HIV-infected persons appears high and may parallel the increasing prevalence 
of suicidal behaviour in South Africa. 
Objective. To construct a brief suicide risk screening scale (SRSS) as a self-administered instrument to screen for suicidal 
ideation in recently diagnosed HIV-infected persons.
Methods. An SRSS was developed, drawing 14 items from two established screening tests, and assessed using a sample of 150 
HIV-infected consenting adults identified at a voluntary counselling and testing (VCT) clinic at an academic district level 
hospital in Durban, South Africa. Participants returned three weeks after their initial assessment for a re-assessment. 
Results. The internal consistency of the SRSS was good (Cronbach’s alpha, 0.87), and its sensitivity (81%) was higher than its 
specificity (47%). The findings suggest that, despite certain limitations, the SRSS may be a valuable screening tool for suicidal 
ideation at VCT clinics. 
Conclusion. Screening for suicide risk and possible suicidal behaviour in HIV-positive persons may form a routine aspect of 
comprehensive patient care at VCT clinics to assist with effective prevention and treatment.
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Globally, suicide and HIV/AIDS remain two 
of the greatest healthcare issues, particularly 
in low- and middle-income countries where 
approximately 85% of suicides occur.[1-3] The 
World Health Organization (WHO) predicted 
that global suicide mortality will increase to 1.53 million 
per annum by the year 2020.[2] Suicide mortality rates have 
changed significantly in South Africa (SA) since apartheid, 
with differences evident across cities, races and gender.[4] SA 
has a relatively high 12-month prevalence of anxiety and mood 
disorders compared with other countries, which adds to the 
burden of suicide risk.[5] In 2007 the overall rates for suicide 
in SA were high (0.9/100 000),[6] and there is an increasing 
occurrence of suicide among youth and men, consistent with 
the international trend.[7] At least one suicide is committed 
every hour in SA, and 20 more unsuccessful attempts are made 
in the same time-span, with one-third of non-fatal attempts 
recorded among youth.[6-8]
The risk factors for suicide are diverse and inter-related, 
and may be particularly complex in HIV-infected individuals. 
One systematic literature review showed a high suicidal risk 
in persons with HIV: 19.7% were described as generally 
suicidal, 26.9% as having suicidal ideation and 9.4% completed 
suicides.[9] There is also a high rate of lifetime suicide risk 
associated with depression.[10] The prevalence of depression 
and anxiety in people living with HIV/AIDS is almost double 
that of HIV-negative individuals.[11] 
There is growing evidence that this is true in SA and 
other African countries.[12,13] The risk of suicide appears to be 
increasing in the context of the HIV epidemic. [14,15] Several SA 
studies have documented a correlation between suicidality 
and HIV at different points in disease progression,[12,13-18] 
including the high prevalence of suicidal ideation among 
HIV-positive pregnant mothers.[16] In a recent study 
conducted among HIV-positive persons in SA, suicidal 
ideation increased over a 6-week period and was present 
in 24% of the HIV-positive participants following HIV 
counselling and testing.[17] This correlated with results of the 
WHO Multisite Intervention Study on Suicidal Behaviours 
(SUPRE-MISS) community survey, where the highest rates 
of lifetime suicidal thoughts and plans were found in Durban 
(25.4% and 15.6%, respectively).[17,19] Despite the introduction 
of antiretroviral therapy (ART), the suicide rate remains more 
than 3 times higher among HIV-positive persons than in the 
general population.[20] Although the international findings on 
the correlation between suicide and HIV/AIDS are diverse,[10] 
the results show compelling evidence to screen for suicide 
risk and intervene as early as possible.[9,10-12] Despite this, 
the assessment of suicide risk is not a routine aspect of HIV 
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The lack of consistent definitions of suicidal 
behaviour across studies has led to confusion 
in the field of suicidology. Suicidality 
encompasses a range of suicidal behaviours, 
which in turn involve degrees of self-
destruction that may be fatal or non-fatal. 
Suicidal ideation is defined as having the 
intent to commit suicide, wanting to take one's 
own life or thoughts about suicide without 
actually making plans to commit suicide. To 
prevent suicides, healthcare professionals need 
to understand the reasons why people have 
suicidal thoughts or display suicidal behaviour. 
While there are a number of psychometric, 
clinical and biological measures to detect 
suicide risk,[21-23] this risk in itself is difficult 
to measure and predict with high degrees of 
accuracy[23] because of its multifactorial and 
multidimensional nature.
Suicide risk can be assessed by a variety 
of self-report and interviewer-administered 
measures. Selecting a self-report and/or a 
structured-interview format to measure 
suicidal symptoms is a critical decision. For 
example, although interviewer-administered 
measures may allow for greater flexibility for 
conducting appropriate assessments of suicidal 
behaviour, these measures usually require 
more time and expense (for administration 
and training) than self-report measures. 
In contrast, self-report questionnaires may 
be inadequate for measuring suicidality in 
cognitively impaired or highly emotional 
individuals with concentration difficulties, 
although findings in this regard are mixed.[24,25] 
Although self-report measures are often used 
as screening tools, an adequate evaluation of 
suicidality should include both self-report and 
interviewer-administered measures. 
Since its publication in 1974, Beck’s 
Hopelessness Scale (BHS) has become an 
internationally-accepted and widely used 
measure in suicide prevention.[26] The 
scale has been extensively researched and 
validated as a measure to predict suicide and 
is still being used worldwide.[27,28] Although 
depression, hopelessness and suicide correlate 
closely, hopelessness was identified as 
one of the most important psychological, 
predictive and modifiable risk factors.[27,28] In 
this context, the aim of the present study 
was to construct a short, reliable and valid 
instrument with high screening and clinical 
utility with which to screen for suicide risk 
in recently diagnosed HIV-infected persons 
at a  voluntary counselling and testing (VCT) 
clinic in Durban. This was intended to identify 
individuals whose suicidal ideation was severe 




The sample consisted of 150 HIV-infected 
adults, presenting for the first time to 
be tested for HIV at a VCT clinic in an 
academic district-level hospital in Durban. 
All participants who tested HIV-positive 
following VCT were informed about the study 
by the resident VCT counsellor. Participants 
who consented voluntarily were enrolled 
in the study and were asked to complete the 
suicide risk screening scale (SRSS) and the 
SUPRE-MISS instrument at baseline and three 
weeks later. The study was approved by the 
Biomedical Research Ethics Committee of the 
University of KwaZulu-Natal (BF202/09) and 
permission to conduct the study was granted 
by the relevant health institution.
Instruments
Two well-known and extensively used scales 
were utilised to assess aspects of suicidality 
in various population groups, viz. the BHS 
and the Beck Depression Inventory (BDI). 
Although these items do not directly assess 
suicidal behaviour, they measure hopelessness 
and immediate suicide risk. The BHS 
contains 20 true/false items (11 negatively 
and 9 positively phrased), with the severity 
of hopelessness (an indirect indicator of 
suicide risk) calculated by adding the scores 
for the 20 items. The total scores range from 
0 (no hopelessness) to 20 (maximum level 
of hopelessness). The BDI, developed as a 
standardised measurement to assess the grades 
and severity of depression in order to monitor 
the change over time, contains 21 behavioural 
manifestations (items) of depression, which 
Table 1. Suicide risk screening scale
This questionnaire consists of 14 statements (sentences). Please read the statements carefully one by one and answer them. If the statement 
describes your attitude for the past week, including now, write ‘T’ in the block provided. If the statement is false for you, write ‘F’ in the 
block.
Item Statement T or F
V1 I might as well give up because there’s nothing I can do about making things better for myself
V2 I can’t imagine what my life would be like in 10 years
V3 My future seems dark to me
V4 I just don’t get the breaks, and there’s no reason to believe that I will in the future
V5 All I can see ahead of me is unpleasantness rather than pleasantness
V6 I don’t expect to get what I really want 
V7 Things just won’t work out the way I want them to
V8 I never get what I want, so it’s foolish to want anything
V9 It is very unlikely that I would get any real satisfaction in the future
V10 The future seems vague and uncertain to me
V11 There’s no use in really trying to get something I want because I probably won’t get it
V12 I have thoughts of killing myself, but I would not carry it out
V13 I would like to kill myself
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describe the symptoms from low to high. 
The items are scored individually from 0 to 
3; these are added to obtain a total score of 
0 - 63. A value <9 represents no or minimal 
depression, 17 - 29 moderate depression and 
>30 severe depression. Co-morbid conditions 
have been found to affect specificity of severity 
ratings at both the low- and high-end scores.[27] 
Several researchers have used items from both 
scales to validate the use of shorter versions in 
specific populations.[27,29,30] 
For the present study, 14 items were 
selected from these scales to construct the 
SRSS (Table 1). The 11 BHS items selected 
are negatively phrased questions that reflect 
expectations of failure or motivational 
components (items V2, V9, V11, V16, V17, 
V20) and future uncertainty or cognitive 
components (items V4, V7, V12, V14, V18). 
Item selection was based on patient responses 
in the related previous studies, by choosing 
those with the highest and lowest scores at 
the two time-points using the complete BHS 
and BDI.[17,18] What the components measure 
has been addressed in other research.[29,31]
Our rationale for item selection incorporated 
several additional considerations. Firstly, patients 
with extreme pessimism would endorse the 
negative items selected and thus be more likely 
to be scored to have a higher suicide risk. [29,30] 
Secondly, the item-size pool is underscored 
by a theoretical framework that the patients’ 
perceived hopelessness about their situation and 
future could be linked to suicide risk. This 
stems from the premise that cognitions mainly 
centre around an uncertain future and the loss 
of perspective in finding solutions to problems, 
which lead to hopelessness and consequently to 
suicidal ideation or attempt.[26] In line with the 
BHS scoring, the items of the SRSS were scored: 
true = 1; false = 0. 
In the absence of a gold standard, an 
instrument previously tested in the general 
population in Durban was used as a proxy: 
the community survey aspect of SUPRE-MISS, 
based on the European Parasuicide Study 
Interview Schedule, which had been applied 
in the WHO/EURO Multicentre Study on 
Suicidal Behaviour.[19] The following questions 
were asked: (i) ‘Have you ever seriously thought 
about committing suicide?’; (ii) ‘Have you ever 
made a plan for committing suicide?’; (iii) ‘Have 
you ever attempted suicide?’. The SUPRE-MISS 
instruments were pilot-tested, translated into 
different languages and validated. Since the 
SUPRE-MISS instrument was deemed reliable 
to predict suicidal behaviour, it was used as the 
reference to test the validity of the SRSS.
Statistical analysis
SPSS version 10.0 was used for data analysis. 
Receiver operating characteristic (ROC) 
analyses were used to determine the sensitivity, 
specificity and optimal cut-off points of the 
SRSS to predict suicidal ideation. Inter-item 
characteristics, internal consistency, reliability 
and validity analyses were also performed.
Results
The mean age of participants at baseline was 
33.5 years (standard deviation (SD) ±9.4). 
The cut-off points of the SRSS scores and 
their corresponding sensitivity and specificity 
values are shown in Table 2. A cut-off score 
of 4.5 (≥4 being a positive result) achieved 
68% sensitivity and 64% specificity in 
predicting suicidal ideation and is therefore 
the recommended cut-off for the SRSS. In 
establishing cut-off points on the SRSS that 
would optimise sensitivity and specificity via 
ROC analysis, it was decided that, ideally, the 
test should be more sensitive than specific to 
identify as many probable suicidal patients 
as possible. Sensitivity is paramount to 
suicide prediction and was our rationale for 
maximising sensitivity in the present analysis. 
The area under the curve (AUC) in ROC 
analysis was 0.730 at baseline (95% CI 0.64 - 
0.81) and 0.776 at three weeks (95% CI 0.68 
- 0.87) (Figs 1 and 2, respectively).
 
Inter-item characteristics 
and internal consistency 
Table 3 displays the corrected item-total 
correlation at baseline and three weeks later. 
The corrected item total was >0.30 for all 
items except for V2 (‘I can’t imagine what my 
Table 2. SRSS cut-off points and corresponding sensitivity and 
specificity to predict suicidal ideation at baseline and at three weeks
Time-point Cut-off Sensitivity Specificity
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life would be like in ten years’). This item had a corrected item-total 
correlation of 0.333 at baseline and 0.277 three weeks later. Due to 
its potential for ambiguity in some non-clinical samples, it has been 
described as an outlier; in other studies it represented one of the highest-
scoring item responses at different time intervals.[13,17,18] This apparent 
discrepancy can be explained partially by considering various factors. 
For example, for some patients, being told that they have a positive 
HIV status can be an extremely stressful experience that constitutes 
a life crisis. For many, their psychological response can include the 
















Diagonal segments are produced by ties.
Fig. 1. ROC curve of SRSS scores for suicidal ideation immediately post-
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Fig. 2 ROC curve of SRSS scores for suicidal ideation three weeks post-
diagnosis in HIV-infected adults.

















V1 0.475 0.870 5.1333 0.3933 ±0.49013 0.7300 0.919 5.1982 0.3964 ±0.49137
V2 0.333 0.875 4.6667 0.8600 ±0.34815 0.277 0.931 4.7297 0.8649 ±0.34342
V3 0.567 0.865 5.0333 0.4933 ±0.50163 0.669 0.921 5.0991 0.4955 ±0.50225
V4 0.613 0.862 5.1400 0.3867 ±0.48862 0.741 0.918 5.2072 0.3874 ±0.48936
V5 0.612 0.862 5.0333 0.4933 ±0.50163 0.701 0.920 5.1441 0.4505 ±0.49980
V6 0.602 0.863 5.0400 0.4867 ±0.50150 0.618 0.923 5.0991 0.4955 ±0.50225
V7 0.619 0.862 5.0000 0.5267 ±0.50096 0.573 0.924 5.0811 0.5135 ±0.50208
V8 0.670 0.859 5.1533 0.3733 ±0.48531 0.695 0.920 5.1892 0.4054 ±0.49320
V9 0.624 0.861 5.0533 0.4733 ±0.50096 0.740 0.918 5.1712 0.4234 ±0.49634
V10 0.675 0.858 5.0733 0.4533 ±0.49949 0.715 0.919 5.2162 0.3784 ±0.48718
V11 0.605 0.862 5.1467 0.3800 ±0.48701 0.802 0.916 5.2613 0.3333 ±0.47354
V12 0.400 0.872 5.4000 0.1267 ±0.33371 0.675 0.921 5.4414 0.1532 ±0.36177
V13 0.318 0.875 5.4867 0.0400 ±0.19662 0.675 0.921 5.4414 0.1532 ±0.36177
V14 0.318 0.875 5.4867 0.0400 ±0.19662 0.650 0.922 5.4505 0.1441 ±0.35283
SD = standard deviation.
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a death sentence. This, along with the myriad 
of possible other misconceptions, cognitive 
distortions, psychiatric and life-disruption 
complications, a shortage of healthcare 
resources and the fear of not being eligible for, 
or having access to ART,[1] makes it difficult for 
HIV-positive persons to visualise a long-term 
future.
The item-total correlations ranged from 
0.318 to 0.675. At baseline, item V10 (‘The 
future seems vague and uncertain to me’) had 
the best corrected item total (0.675), while 
item V11 (‘There’s no use in really trying to get 
something I want because I probably won’t get 
it’) had the best corrected item total (0.802) at 
three weeks. The Cronbach’s alpha for a deleted 
item showed that none of the items were 
problematic. The level of internal consistency 
for the SRSS was, therefore, acceptable for 
clinical purposes and was consistent with the 
findings of other studies.[27] 
Reliability and validity
The overall Cronbach’s alpha for the SRSS at 
baseline and three weeks was 0.874 and 0.915, 
respectively. To determine the validity of the 
SRSS, it was compared with the accepted 
instrument for SUPRE-MISS. Using a cut-
off score of 4, the sensitivity for the SRSS at 
baseline was 81% with a positive predictive 
value of 48%, a specificity of 47% and a 
negative predictive value of 80%. At three 
weeks, the sensitivity was 79%, the specificity 
55%, the positive predictive value 44%, and the 
negative predictive value 82%. 
Discussion
This study demonstrated the potential utility 
of a simple screening tool to detect suicidality 
in HIV-infected individuals newly diagnosed 
through a VCT programme. Although the 
sensitivity and specificity of the SRSS were 
not very high (around 68%), these compared 
favourably with those obtained in other 
research.[26,29] Unlike other studies, where 
item 7 or the 4 items of the BHS were not 
administered individually, in our study the 
full version of the BHS was administered 
and the responses to the 20 items were used 
to deduce final scores.[29] Notably, there 
was a likelihood of a high level of false-
positives through the use of the SRSS. The 
results indicate a good sensitivity at both 
time-periods and a comparatively low rate 
of false-positives. Further research and the 
incorporation of additional assessment items 
in the questionnaire are likely to have a more 
successful result in suicide prevention.
Equally important for screening instruments 
to be effective is the prevalence of risk within 
the population. It is well documented that 
SA – especially the city of Durban, where 
the research was conducted  – has a high 
prevalence of HIV/AIDS, and a recent study 
showed that sero-positivity, age and gender 
were significantly associated with suicidal 
ideation.[17,18] It can therefore be concluded 
that the SRSS can be used, in conjunction 
with a clinical interview, as a valid screening 
instrument to assess for suicide risk in this 
setting. The use of a clinical interview, which 
remains the fundamental basis of suicide 
risk assessment, should incorporate an 
understanding of the patient’s suicidal crisis 
from both an objective/descriptive as well as 
an experiential perspective.[23-25] The former 
includes objective patient data to assess suicide 
risk, a clinical (psychiatric/psychological) 
history and identification of overt suicidal 
manifestations and risk factors.[23-25] The latter 
perspective goes beyond delineation of clinical 
symptoms in an attempt to understand the 
patient’s actual feelings, personal narrative, 
perspective, sustaining resources and beliefs 
about suicide.[23-25] 
The assessment of hopelessness is extremely 
important in clinical practice, since high levels 
of hopelessness can lead to isolation and the 
inhibition to seek help timeously. Given this, 
VCT offers patients an option to be counselled 
and tested for the presence of HIV and, at the 
same time, provides an opportunity to identify 
any underlying level of hopelessness and 
suicide risk related to receiving a life-altering 
diagnosis of HIV-positivity.[17,18] The self-
administered questionnaire can be completed 
while patients are awaiting their HIV test 
results. The questionnaire is easily scored and 
a risk assessment is performed with relative 
ease. A suicide intervention to be included 
in the post-test counselling is presently being 
evaluated, including re-administering the SRSS 
at the next clinical visit. This may decrease the 
rate of false-positives obtained. 
Study limitations
The construction of the SRSS involved 
selecting items from two sub-scales, which 
were grouped and analysed as a single scale. 
The main limitation of this study was that 
there was no gold standard to use as a baseline 
reference within the context of the population 
studied. Furthermore, there was no reference 
to the participants’ views on living with HIV, 
which can be part of a clinical interview; this 
should form the focus of further research. 
Conclusion
Analyses have demonstrated the importance of 
brief scales with high clinical validity for assessing 
suicidal risk in daily clinic settings.[21,22] Our 
research shows that the SRSS can be a valuable 
screening tool for suicidality as part of a standard 
clinical interview and good clinical assessment in 
HIV/AIDS VCT clinics. Suicide risk assessment 
in patients seen at such clinics should be a routine 
aspect of comprehensive patient care, to assist 
with effective management and the prevention 
of possible suicidal behaviour. The SRSS is not 
intended as a stand-alone diagnostic tool to assess 
suicidal behaviour, but may be used as a triage tool 
to assist in the identification of high-risk patients.
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